Interleukin-6 as a prognostic biomarker of clinical outcomes after traumatic brain injury: a systematic review

Traumatic brain injury (TBI) is a major cause of mortality and morbidity worldwide. There are currently no early biomarkers for prognosis in routine clinical use. Interleukin-6 (IL-6) is a potential biomarker in the context of the established role of neuroinflammation in TBI recovery. Therefore, a s...

Descripción completa

Detalles Bibliográficos
Autores principales: Ooi, Setthasorn Zhi Yang, Spencer, Robert James, Hodgson, Megan, Mehta, Samay, Phillips, Nicholas Lloyd, Preest, Gwilym, Manivannan, Susruta, Wise, Matt P, Galea, James, Zaben, Malik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256073/
https://www.ncbi.nlm.nih.gov/pubmed/35790656
http://dx.doi.org/10.1007/s10143-022-01827-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256073/
https://www.ncbi.nlm.nih.gov/pubmed/35790656
http://dx.doi.org/10.1007/s10143-022-01827-y

Ejemplares similares